Crackdown on Substandard Drugs: 143 Samples Identified
The Central Drugs Laboratories identified 46 drug samples as substandard in July 2025. State labs found 97 more. Some non-standard drugs came from Bihar and Ghaziabad, made by unauthorised firms. Investigations are ongoing. Routine checks help remove these substandard drugs from the market.
- Country:
- India
The Central Drugs Laboratories, in its monthly alert for July 2025, flagged 46 drug samples as not meeting standard quality criteria, according to health ministry officials.
State drug testing labs identified an additional 97 samples substandard. Continual regulatory surveillance reveals the list of non-standard and spurious drugs on the Central Drugs Standard Control Organisation (CDSCO) website monthly.
In July 2025, investigations revealed unauthorised manufacturers in Bihar and Ghaziabad had produced several spurious drug samples, warranting an ongoing investigation. This routine identification process, in cooperation with state regulators, aims to promptly withdraw substandard drugs from circulation.
(With inputs from agencies.)
Advertisement
Google News